MarketsStocksNECLIFE
NE

Nectar Lifesciences Ltd

NSE: NECLIFEBSE: 532649Healthcare
Download Research Report7-page PDF
11.74
-1.84%
NSE · auto-updates while market open
Prev Close
₹24.25
Day High
₹12.10
Day Low
₹11.55
Mkt Cap
₹220 Cr
P / E
-
P / B
0.4
ROE
-38.1%
52W High
₹25.50
52W Low
₹9.30
Key Metrics
Market Cap
₹220 Cr
P / E
-
P / B
0.38
EV / EBITDA
23.26
ROCE
-4.0%
ROE
-38.1%
Debt / Equity
0.00
Book Value
₹29.97
EPS
-
Div Yield
0.0%
Face Value
₹1
Promoter Holding
51.8%
Revenue · ₹ Cr
2.4k
FY20
1.5k
FY21
1.7k
FY22
1.5k
FY23
1.7k
FY24
1.7k
FY25
9
FY26
Net Profit · ₹ Cr
32
25
5
-73
-24
-114
-293
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹2.6
₹2.1
₹1.4
₹1.1
₹0.2
₹-3.3
₹-1.1
FY16FY19FY20FY21FY22FY23FY24
P / E Ratio · price ÷ TTM EPS
0831672504-70-17Jun 21Feb 23Oct 24Jun 26
P/E 30.2×Median 85.4×TTM EPS
Q1 2026 snapshot
Sales
₹8 Cr
Operating profit
-
OPM
-
Net profit
₹-68 Cr
EPS
-
Scorecard · 7 axes
Quality
Weak
33/100
Valuation
-
Growth
Bad
-21.2%
Profitability
Bad
-21.1%
Performance
Bad
-51.0%
Entry Point
Strong
46%
Red Flags
Strong
0 flags
Shareholding Pattern
51.8%Promoter
Promoter51.8%
FII0.6%
DII4.0%
Public43.5%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue454.982430.77281.025.740.667.58
Net Profit7.84-130.089-63.231-176.00614.27-67.924
NPM %1.7%-30.2%-22.5%-3066.3%2162.1%-896.1%
AlertPre-trade